Epoch Investment Partners Inc. grew its position in shares of Liberty Global PLC Class A (NASDAQ:LBTYA) by 1.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,946,065 shares of the company’s s

Loxo Oncology (NASDAQ:LOXO) is scheduled to be announcing its earnings results before the market opens on Thursday, August 9th. Analysts expect the company to announce earnings of ($0.54) per share for the quarter.

Loxo Oncology (NASDAQ:LOXO) last posted its earnings results on Tuesday,

One deal was for $4.3 billion to purchase Tibco Software. Another was a $6.5 billion acquisition of Solera. In the last eight years, Vista Equity Partners, a private equity firm based in Austin, Tex., has conducted 204 software acquisitions, more than Google, Oracle, or any tech company or financial firm in the world. The deals involve companies that sell business software to just about every industry, ranging from banks and hospitals to school districts and nonprofits.

The man behind this deal machine is Brian Sheth, the 42-year-old president of Vista Equity. Sheth co-founded Vista in 2000 with Robert Smith, Vista&a;rsquo;s CEO. The duo formed a tight partnership and work together closely, but Sheth has been overseeing most of Vista&a;rsquo;s deal-making activities in recent years. That means no person on the planet is overseeing more software deals than Sheth. His estimated net worth is $2 billion.

Top 5 Tech Stocks To Watch For 2019: Ambarella, Inc.(AMBA)

Advisors’ Opinion:

[By Chris Lange]

Ambarella Inc. (NASDAQ: AMBA) is expected to report its fiscal first-quarter results on Tuesday. The analysts consensus forecast is EPS of $0.09 on $56.14 million in revenue. Shares were changing hands at $49.15 as last week came to a close. The consensus price target is $59.38, and the stock has a 52-week range of $40.06 to $66.23.

[By Harsh Chauhan]

Investors’ enthusiasm for Ambarella (NASDAQ:AMBA)came crashing down after the video-processing-chip specialist’s fiscal first-quarter performance didn’t do much to dispel fears that it was finding it difficult to grow despite operating in verticals that promise a lot of opportunities.

[By Nicholas Rossolillo]

In light of this, investors are presented with a choice: invest in a well-established leader like Intel (NASDAQ:INTC) or an upstart looking to make waves with new innovation like Ambarella (NASDAQ:AMBA). Which one you buy will have a lot to do with how much uncertainty you can stomach.

[By Chris Hill]

On the other side of the overreaction coin, video-processing chipmaker Ambarella (NASDAQ:AMBA)dropped a whopping 13% on its quarterly report, but the company’s long-term outlook is a bit less rosy. The mysterious JPHathAzon healthcare company has reportedly decided on a CEO, but further details haven’t yet been released. And Warren Buffett and Jamie Dimon are weighing in on quarterly expectations culture. Click play and find out more.

[By Leo Sun]

Chipmakers Ambarella (NASDAQ:AMBA) and AMD’s (NASDAQ:AMD) fortunes diverged sharply this year. Ambarella’s stock tumbled over 25%, due to concerns about its slowing sales growth and its ability to keep up with technological shifts, while AMD rallied nearly 60% as investors cheered its comeback against Intel (NASDAQ:INTC).

Top 5 Tech Stocks To Watch For 2019: Celestica, Inc.(CLS)

Advisors’ Opinion:

[By Peter Graham]

A long term performance chart shows shares of small cap Sanmina Corp (NASDAQ: SANM), a previous Elite Opportunity Pro (EOP) newsletter suggestion as the next breakout stock, andmid cap Flextronics International being bigger winners (albeit FLEX has steadily risen for two years while SANM has already peaked) compared with the moderately positive performance of mid cap Jabil Circuit, Inc (NYSE: JBL) and small cap Celestica Inc (NYSE: CLS):

[By Ethan Ryder]

These are some of the headlines that may have effected Accern Sentiment Analysis’s scoring:

A number of equities research analysts have recently issued reports on the company. TheStreet upgraded Celestica from a “c+” rating to a “b-” rating in a research note on Monday, May 7th. Zacks Investment Research cut Celestica from a “hold” rating to a “sell” rating in a research note on Thursday, May 3rd. Royal Bank of Canada upped their price objective on Celestica from $11.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Monday, April 30th. Finally, Beacon Securities reiterated a “buy” rating on shares of Celestica in a research note on Monday, January 29th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $13.27.

[By Logan Wallace]

Get a free copy of the Zacks research report on Celestica (CLS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

[By Joseph Griffin]

Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp lessened its holdings in Celestica Inc (NYSE:CLS) (TSE:CLS) by 18.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,492,435 shares of the technology company’s stock after selling 343,300 shares during the period. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp owned 1.20% of Celestica worth $19,894,000 as of its most recent filing with the Securities and Exchange Commission.

Top 5 Tech Stocks To Watch For 2019: Cerner Corporation(CERN)

Advisors’ Opinion:

[By Ethan Ryder]

Simulations Plus (NASDAQ: SLP) and Cerner (NASDAQ:CERN) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, dividends, earnings and risk.

[By Joseph Griffin]

New York State Teachers Retirement System lifted its holdings in Cerner (NASDAQ:CERN) by 1.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 460,773 shares of the company’s stock after purchasing an additional 6,011 shares during the quarter. New York State Teachers Retirement System owned 0.14% of Cerner worth $26,725,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

[By Joseph Griffin]

Get a free copy of the Zacks research report on Cerner (CERN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

[By Keith Speights]

Veeva Systems (NYSE:VEEV) and Cerner Corporation (NASDAQ:CERN) stand out as two of the top providers of these healthcare systems. Veeva has definitely been the bigger winner lately, with its stock soaring nearly 40% so far in 2018. Meanwhile, Cerner stock is down more than 10% year to date.

Top 5 Tech Stocks To Watch For 2019: Intuit Inc.(INTU)

Advisors’ Opinion:

[By Daniel Sparks]

With its fiscal third-quarter earnings report behind it, it’s clear that Intuit’s (NASDAQ:INTU) momentumhas persisted. Not only did the financial software company report double-digit revenue growth in its consumer group and its small-business and self-employed group, but management also raised its outlook for fiscal 2018 revenue, operating income, and earnings per share. Fueled by a well-executed tax season, Intuit benefited from strength in its do-it-yourself returns and higher average revenue per return.

[By Money Morning Staff Reports]

This has major financial institutions issuing warnings ahead of one of the biggest technological shifts in the history of the world.

The Top Cryptocurrency Stories for Wednesday
Yesterday, one of Bitcoin’s biggest proponents once again released an extremely bullish outlook on the cryptocurrency. Billionaire investor Tim Draper said Tuesday that “Bitcoin is bigger than the Internet,” and he also said its influence will be even bigger than the Industrial Revolution, the Renaissance, and the Iron Age. The statement comes after he released a recent price target of $250,000 by 2022. Not everyone is buying into Bitcoin’s post-tax season rally. Bill Harris, the former CEO of PayPal Holdings Inc. (Nasdaq: PYPL) and Intuit Inc. (Nasdaq: INTU), sounded off Tuesday in an op-ed piece titled “Bitcoin Is the Greatest Scam in History.” Harris called the cryptocurrency a “colossal pump-and-dump scheme” that has no precedent on the world stage. Bitcoin proponents immediately took to social media and online blogs to refute Harris’ arguments. Forbes contributor Kyle Torpey vented that Harris’ focus was misguided and took special issue with his claim that “Bitcoin has no value.” The crypto world has identified JPMorgan Chase & Co. (NYSE: JPM) CEO Jamie Dimon as public enemy No. 1. Computer security pioneer and cryptocurrency guruJohn McAfeecalled out Dimon for attempting – and failing – to “end crypto.” McAfee lobbed a slew of accusations at the big banker via Twitter Inc. (NYSE: TWTR). Finally, it wouldn’t be another day in the cryptocurrency markets without another unprovoked threat to Bitcoin. The latest comes from the Massachusetts Institute of Technology (MIT). In a recent issue of the MIT Technology Review, writers presented three scenarios that could “destroy Bitcoin.” The scenarios include a “government takeover” of the cryptocurrency, the “tokenization of everything” that involves a massive influx of tokens and makes Bitcoin less valuable, and a mas

[By Lisa Levin]

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

After the markets close, Intuit Inc. (NASDAQ: INTU) is projected to post quarterly earnings at $4.6 per share on revenue of $2.80 billion. Intuit shares gained 0.08 percent to $191.85 in after-h

CIRCOR International (NYSE: CIR) and ARC Group WorldWide (NASDAQ:ARCW) are both small-cap industrial products companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, valuation, profitability and institutional ownership.

[By Ethan Ryder]

Watts Water Technologies (NYSE: WTS) and ARC Group WorldWide (NASDAQ:ARCW) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

[By Joseph Griffin]

News articles about ARC Group WorldWide (NASDAQ:ARCW) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. ARC Group WorldWide earned a news sentiment score of 0.08 on Accern’s scale. Accern also assigned media coverage about the technology company an impact score of 45.8235732272447 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

[By Shane Hupp]

Barnes Group (NYSE: B) and ARC Group WorldWide (NASDAQ:ARCW) are both industrial products companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.

That didn’t take long. After a one-week absence as the Dow Jones Industrial Average (DJIA) index’s best performing stock, Boeing Co. (NYSE: BA) has reclaimed its top ranking last week with a gain of nearly 9%. For the first two weeks of 2018, Boeing shares have added 14%.

The second-best performer among the Dow 30 so far this year is Caterpillar Inc. (NYSE: CAT), up just over 8%, and it was the Dow’s second-best performer for all of 2017. General Electric Co. (NYSE: GE) held the top spot in the first week of the yearbut slid to third-best last week with two-week total share price jump of 7.5%. United Technologies Corp. (NYSE: UTX) has posted a gain of just over 7% to settle into the fourth spot.

The Dow posted an all-time high of 25,810.43 on Friday and closed the week at 25,803.19, up about 540 points (about 2.1%). The index gained about 1.9% in the first week of the year.

Last Monday, Boeing announced full-year orders and deliveries of both commercial and defense aircraft. On the commercial side, the company delivered 763 jets, a new record total surpassing by one 2015’s total. Total net new orders for the year came to 912 and pushed the company’s total backlog to 5,864 commercial jets. The ratio of new orders to delivered planes (the book-to-bill ratio) was about 1.2 for the year.

Top 10 Performing Stocks To Invest In Right Now: State Auto Financial Corporation(STFC)

Advisors’ Opinion:

[By Ethan Ryder]

State Auto Financial (NASDAQ:STFC) was upgraded by equities researchers at BidaskClub from a “buy” rating to a “strong-buy” rating in a research note issued on Friday.

[By Shane Hupp]

Ancora Advisors LLC trimmed its position in shares of State Auto Financial Corp (NASDAQ:STFC) by 18.4% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 29,977 shares of the insurance provider’s stock after selling 6,762 shares during the period. Ancora Advisors LLC owned about 0.07% of State Auto Financial worth $856,000 as of its most recent SEC filing.

[By Logan Wallace]

W. R. Berkley (NYSE: WRB) and State Auto Financial (NASDAQ:STFC) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and risk.

Top 10 Performing Stocks To Invest In Right Now: Bankwell Financial Group, Inc.(BWFG)

Advisors’ Opinion:

[By Logan Wallace]

Research analysts at Boenning Scattergood started coverage on shares of Bankwell Financial Group (NASDAQ:BWFG) in a report issued on Thursday, The Fly reports. The firm set an “outperform” rating on the bank’s stock.

[By Shane Hupp]

Get a free copy of the Zacks research report on Bankwell Financial Gr (BWFG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Invest In Right Now: OSI Systems, Inc.(OSIS)

Advisors’ Opinion:

[By Shane Hupp]

Get a free copy of the Zacks research report on OSI Systems (OSIS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

[By Logan Wallace]

Millennium Management LLC lessened its stake in shares of OSI Systems, Inc. (NASDAQ:OSIS) by 40.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 255,483 shares of the technology company’s stock after selling 170,680 shares during the quarter. Millennium Management LLC owned about 1.41% of OSI Systems worth $16,675,000 at the end of the most recent reporting period.

[By Shane Hupp]

Here are some of the headlines that may have impacted Accern’s rankings:

OSIS has been the subject of several research reports. Sidoti initiated coverage on OSI Systems in a research note on Wednesday, February 21st. They issued a “buy” rating for the company. Zacks Investment Research raised OSI Systems from a “hold” rating to a “buy” rating and set a $69.00 price objective for the company in a research note on Wednesday, April 4th. ValuEngine lowered OSI Systems from a “hold” rating to a “sell” rating in a research note on Wednesday, May 2nd. Jefferies Group lowered OSI Systems from a “buy” rating to a “hold” rating and dropped their price objective for the company from $79.00 to $70.00 in a research note on Friday, February 2nd. They noted that the move was a valuation call. Finally, BidaskClub lowered OSI Systems from a “sell” rating to a “strong sell” rating in a research note on Saturday, January 20th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $86.20.

Top 10 Performing Stocks To Invest In Right Now: Neuberger Berman MLP Income Fund Inc.(NML)

Advisors’ Opinion:

[By Ethan Ryder]

New Millennium Iron Corp (TSE:NML)’s share price reached a new 52-week low during trading on Monday . The stock traded as low as C$0.07 and last traded at C$0.07, with a volume of 21500 shares traded. The stock had previously closed at C$0.07.

Top 10 Performing Stocks To Invest In Right Now: Intrepid Potash, Inc(IPI)

Advisors’ Opinion:

[By Dan Caplinger]

Stocks rebounded on Wednesday, with the Dow Jones Industrial Average climbing back from triple-digit losses early in the session to finish with a modest gain. Market participants were initially nervous because of the continued upward pressure on interest rates and their potential negative impact on the U.S. economy. But later in the day, confidence returned, and the steadfast market reversed course. Several individual stocks had much larger advances. Norfolk Southern (NYSE:NSC), Six Flags Entertainment (NYSE:SIX), and Intrepid Potash (NYSE:IPI) were among the best performers on the day. Here’s why they did so well.

[By Shane Hupp]

Intrepid Potash (NYSE:IPI)’s share price was down 5.8% on Tuesday following insider selling activity. The stock traded as low as $4.00 and last traded at $4.05. Approximately 1,663,655 shares changed hands during trading, an increase of 53% from the average daily volume of 1,087,289 shares. The stock had previously closed at $4.30.

Top 10 Performing Stocks To Invest In Right Now: Chesapeake Utilities Corporation(CPK)

Advisors’ Opinion:

[By Joseph Griffin]

Chesapeake Utilities Co. (NYSE:CPK) insider Stephen C. Thompson sold 1,772 shares of the company’s stock in a transaction that occurred on Tuesday, June 19th. The stock was sold at an average price of $77.21, for a total transaction of $136,816.12. Following the transaction, the insider now owns 73,605 shares in the company, valued at $5,683,042.05. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

[By Logan Wallace]

Get a free copy of the Zacks research report on Chesapeake Utilities (CPK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

[By Lisa Levin] Companies Reporting Before The Bell
Anheuser-Busch InBev SA/NV (NYSE: BUD) is estimated to report quarterly earnings at $0.89 per share on revenue of $13.06 billion.
SINA Corporation (NASDAQ: SINA) is expected to report quarterly earnings at $0.42 per share on revenue of $433.32 million.
Weibo Corporation (NASDAQ: WB) is projected to report quarterly earnings at $0.47 per share on revenue of $342.39 million.
Ameren Corporation (NYSE: AEE) is estimated to report quarterly earnings at $0.57 per share on revenue of $1.55 billion.
Mylan N.V. (NASDAQ: MYL) is projected to report quarterly earnings at $0.98 per share on revenue of $2.75 billion.
Cinemark Holdings, Inc. (NYSE: CNK) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.51 billion.
ADT Inc. (NYSE: ADT) is expected to report quarterly earnings at $0.24 per share on revenue of $1.11 billion.
Coty Inc. (NYSE: COTY) is projected to report quarterly earnings at $0.13 per share on revenue of $2.18 billion.
Pinnacle Entertainment, Inc. (NYSE: PNK) is estimated to report quarterly earnings at $0.31 per share on revenue of $644.94 million.
Conduent Incorporated (NYSE: CNDT) is estimated to report quarterly earnings at $0.21 per share on revenue of $1.44 billion.
Delphi Technologies PLC (NYSE: DLPH) is projected to report quarterly earnings at $1.16 per share on revenue of $1.25 billion.
Office Depot, Inc. (NASDAQ: ODP) is expected to report quarterly earnings at $0.08 per share on revenue of $2.72 billion.
Global Partners LP (NYSE: GLP) is estimated to report quarterly earnings at $0.13 per share on revenue of $2.33 billion.
Wolverine World Wide, Inc. (NYSE: WWW) is projected to report quarterly earnings at $0.37 per share on revenue of $530.99 million.
Performance Food Group Company (NYSE: PFGC) is expected to report quarterly earnings at $0.32 per share on revenue of $4.46 billion.
Groupon, Inc. (NASDAQ: GRPN) is projected to report

[By Ethan Ryder]

Get a free copy of the Zacks research report on Chesapeake Utilities (CPK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

[By Ethan Ryder]

Lord Abbett & CO. LLC lowered its position in shares of Chesapeake Utilities Co. (NYSE:CPK) by 22.7% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 39,400 shares of the utilities provider’s stock after selling 11,600 shares during the quarter. Lord Abbett & CO. LLC owned 0.24% of Chesapeake Utilities worth $2,772,000 as of its most recent filing with the SEC.

Top 10 Performing Stocks To Invest In Right Now: Arc Wireless Solutions Inc.(ARCW)

Advisors’ Opinion:

[By Ethan Ryder]

Watts Water Technologies (NYSE: WTS) and ARC Group WorldWide (NASDAQ:ARCW) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

[By Shane Hupp]

Barnes Group (NYSE: B) and ARC Group WorldWide (NASDAQ:ARCW) are both industrial products companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.

[By Max Byerly]

CIRCOR International (NYSE: CIR) and ARC Group WorldWide (NASDAQ:ARCW) are both small-cap industrial products companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, valuation, profitability and institutional ownership.

[By Joseph Griffin]

News articles about ARC Group WorldWide (NASDAQ:ARCW) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. ARC Group WorldWide earned a news sentiment score of 0.08 on Accern’s scale. Accern also assigned media coverage about the technology company an impact score of 45.8235732272447 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Top 10 Performing Stocks To Invest In Right Now: Cullen/Frost Bankers, Inc.(CFR)

Advisors’ Opinion:

[By Ethan Ryder]

Get a free copy of the Zacks research report on Cullen/Frost Bankers (CFR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

[By Joseph Griffin]

BlackRock Inc. grew its stake in shares of Cullen/Frost Bankers, Inc. (NYSE:CFR) by 2.8% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,251,719 shares of the bank’s stock after acquiring an additional 140,956 shares during the period. BlackRock Inc. owned about 8.23% of Cullen/Frost Bankers worth $557,051,000 at the end of the most recent quarter.

In that spirit, we asked a few of our Motley Fool investors what they see as the best investment ideas at the start of July, 2018. They were quick to suggest Chinese e-commerce giantBaidu(NASDAQ:BIDU), coffee giant Starbucks (NASDAQ:SBUX), clean energy specialist TerraForm Power (NASDAQ:TERP), semiconductor veteran Intel, (NASDAQ:INTC), and Texan bankCullen/Frost Bankers(NYSE:CFR).

[By Stephan Byrd]

Get a free copy of the Zacks research report on Cullen/Frost Bankers (CFR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Invest In Right Now: Churchill Downs, Incorporated(CHDN)

[By Lisa Levin] Gainers
Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
BioTelemetry,

[By Logan Wallace]

Churchill Downs Incorporated (NASDAQ:CHDN)’s share price reached a new 52-week high and low during mid-day trading on Tuesday . The stock traded as low as $301.60 and last traded at $297.40, with a volume of 6596 shares trading hands. The stock had previously closed at $292.50.

[By Shane Hupp]

Here are some of the media headlines that may have effected Accern Sentiment’s analysis:

A number of research firms recently weighed in on CHDN. Telsey Advisory Group upped their price target on Churchill Downs from $265.00 to $290.00 and gave the stock a “market perform” rating in a report on Monday, May 7th. ValuEngine raised Churchill Downs from a “hold” rating to a “buy” rating in a report on Friday, April 27th. Zacks Investment Research cut Churchill Downs from a “buy” rating to a “hold” rating in a report on Tuesday, March 20th. Finally, BidaskClub raised Churchill Downs from a “buy” rating to a “strong-buy” rating in a report on Tuesday, April 24th. Three analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. Churchill Downs currently has an average rating of “Buy” and a consensus price target of $260.50.

Top 10 Performing Stocks To Invest In Right Now: Ellie Mae, Inc.(ELLI)

Advisors’ Opinion:

[By Logan Wallace]

Get a free copy of the Zacks research report on Ellie Mae (ELLI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

[By Max Byerly]

Schwab Charles Investment Management Inc. boosted its stake in shares of Ellie Mae Inc (NYSE:ELLI) by 3.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 166,934 shares of the software maker’s stock after purchasing an additional 5,916 shares during the period. Schwab Charles Investment Management Inc.’s holdings in Ellie Mae were worth $15,348,000 at the end of the most recent reporting period.

[By Matthew Cochrane]

Another big deal announced by First Data during the conference call was the exclusive right to process payments for the mortgage software platform powered by Ellie Mae (NYSE:ELLI). All future appraisal and application fees collected by Ellie Mae will be facilitated by First Data. Ellie Mae’s software processes more than a third of all mortgage loan applications in the U.S.

[By Brian Stoffel]

We’ll cover each of those below for these five growth stocks.

Company What it does…
Mercadolibre(NASDAQ:MELI) Leading e-commerce player in Latin America
Axon Enterprises(NASDAQ:AAXN) Develops products for police forces: TASERs, body cameras, and a database to store and analyze footage
Shopify(NYSE:SHOP) Helps merchants create an e-commerce presence
Ellie Mae(NYSE:ELLI) Offers platform to help streamline mortgage origination and refinancing business
Paycom Solutions(NYSE:PAYC) Maintains and develops cloud solutions for HR departments

Chart by author.

[By Logan Wallace]

Get a free copy of the Zacks research report on Ellie Mae (ELLI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

[By Max Byerly]

Get a free copy of the Zacks research report on Ellie Mae (ELLI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Whether you’re ready for it or not, the marijuana industry is flowering before our eyes. In North America, cannabis research firm ArcView, in partnerships with BDS Analytics, has projected sales growth of 28% through 2021. If this estimate proves accurate, we could be looking at almost $25 billion in annual North American legal weed sales in just a few years.

All eyes are on Canada

Though the entire world has seemingly looked to the U.S. to lead the charge of cannabis progressivism, it’s stepped aside and allowed Canada to grab the reins. Despite 30 U.S. states having legalized marijuana in some capacity, the federal government and Attorney General Jeff Sessions have been unwavering on pot’s Schedule I classification — i.e., wholly illegal, prone to abuse, and having no recognized medical benefits.

Image source: Getty Images.

Top 10 Heal Care Stocks To Own For 2018: Arc Wireless Solutions Inc.(ARCW)

Advisors’ Opinion:

[By Ethan Ryder]

Watts Water Technologies (NYSE: WTS) and ARC Group WorldWide (NASDAQ:ARCW) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

[By Jim Robertson]

On Thursday, our Under the Radar Moversnewsletter suggested small cap manufacturing and 3D printing service provider ARC Group WorldWide (NASDAQ: ARCW) as a short trade:

Top 10 Heal Care Stocks To Own For 2018: Computer Programs and Systems Inc.(CPSI)

Advisors’ Opinion:

[By Lisa Levin]

Shares of Computer Programs & Systems, Inc. (NASDAQ: CPSI) were down 31 percent to $27.00 after the company posted weaker-than-expected Q2 results.

Top 10 Heal Care Stocks To Own For 2018: Uni-Pixel, Inc.(UNXL)

Advisors’ Opinion:

[By Roberto Pedone]

Uni-Pixel (UNXL) manufactures electronic film products using its proprietary manufacturing process, UniBoss. This stock closed up 7.6% to $16.84 in Monday’s trading session.

Monday’s Volume: 1.88 million

Three-Month Average Volume: 1 million

Volume % Change: 108%

From a technical perspective, UNXL bounced sharply higher here right off its 50-day moving average of $15.89 with above-average volume. This stock looks to be forming a double bottom chart pattern at $14.91 to $15.16. If that bottom holds, then shares of UNXL could see a continuation of Monday’s upside action.

Traders should now look for long-biased trades in UNXL as long as it’s trending above $15.16 or $14.91 and then once it sustains a move or close above Monday’s high of $17.53 with volume that hits near or above 1 million shares. If we get that move soon, then UNXL will set up to re-test or possibly take out its next major overhead resistance level at its 200-day moving average of $19.89.

[By Lisa Levin]

Shares of UniPixel Inc (NASDAQ: UNXL) were down 22 percent to $1.63 after the company announced a public offering of newly issued shares of stock. UniPixel plans to offer 5.35 million shares of its own stock at a public offering price of $1.50 per share with the option for its underwriters to purchase up to an additional 802,500 shares.

[By Peter Graham]

Small cap sensor film stockUniPixel Inc (NASDAQ: UNXL) reportedQ1 2017 earnings after the Thursday market close withshares falling both on Thursday and in afterhours trading. UniPixel is not well covered or known by analysts yet and this can make shares volatile. However and last September, we had suggested a long position in the stock based upon technicals by saying:

Top 10 Heal Care Stocks To Own For 2018: Canon, Inc.(CAJ)

Advisors’ Opinion:

[By Paul R. La Monica]

Miscellaneous shorts. Lamensdorf is also betting against Japanese printer and camera giant Canon (CAJ) since he believes the company still hasn’t figured out a way to compete with smartphones.

[By Dan Carroll]

Nikon’s story is similar to what’s plaguing its Japanese rival, Canon (NYSE: CAJ ) . Canon’s stock has nosedived by 20% year to date, but the stock’s recovered nearly 3% over the past month. Don’t let appearances fool you: The company slashed its full-year sales and profit forecasts back in July, as the worldwide camera market has slumped, and as smartphones continue to take over this aging niche. Canon’s route back to respectability looks like a treacherous climb.

Top 10 Heal Care Stocks To Own For 2018: Aclaris Therapeutics, Inc.(ACRS)

Advisors’ Opinion:

[By Chris Lange]

Aclaris Therapeutics Inc. (NASDAQ: ACRS) saw its shares make a handy gain on Friday after the company announced the pricing of its secondary offering. The company intends to price its 4 million shares at $22.75 per share, with an overallotment option for an additional 600,000 shares. At this price the entire offering is valued up to $104.65 million.

[By Peter Graham]

Small cap hair loss stocks Aclaris Therapeutics (NASDAQ: ACRS), Cytori Therapeutics (NASDAQ: CYTX) and RepliCel Life Sciences (OTCQB: REPCF; CVE: RP) are trying to tap into a big market as currently, there are only two FDA-approved drugs available for the treatment of Androgenetic Alopecia (AGA) -also known as male or female pattern baldness (one of which cannot be used by women). Thus, a significant unmet need exists for a safe andefficacious product especially since its experienced by 70% of men and 40% of women as they age.

Similarly, Twitter is also the biggest holding in the Firsthand Technology Value Fund (SVVC). With just over 1 million shares of the social media platform, Twitter represents nearly 11% of the total portfolio as of mid-year. Shares of Firsthand Technology Value jumped more than 6% Friday.

Top 10 Heal Care Stocks To Own For 2018: Helios and Matheson Analytics Inc(HMNY)

Advisors’ Opinion:

[By Cameron Saucier]

Helios and Matheson Analytics Inc. (Nasdaq: HMNY) is an information technology company that provides its clients predictive analytics. The company uses big data for most of its software and operates within the financial services, insurance, and healthcare industries. HMNY is up 278% YTD after it announced a strategic merger with a GPS application company, called RedZone Maps. RedZone is known for mapping crime in major cities. News of the merger sent HMNY climbing over 1,000% from $1.11 per share to $13.75 per share over the course of a week. The stock has since fallen to $5.23 per share as of Monday intraday.

[By Paul Ausick]

The subscription service is controlled by Helios & Matheson Analytics Inc. (NASDAQ: HMNY), which owns about 81% of MoviePass stock.

Small cap analytics stock Helios and Matheson Analytics (NASDAQ: HMNY) is thethird most shorted stock on the NASDAQ with short interest of 54.30% according to Highshortinterest.com. Helios and Matheson Analytics is a provider of information technology services and solutions, offering a range of technology platforms focusing on big data, artificial intelligence, business intelligence, social listening, and consumer-centric technology. The Company owns a majority interest in MoviePass Inc., the nation’s premier movie-theater subscription service.Other holdings include RedZone Map, a safety and navigation app for iOS and Android users, and a community-based ecosystem that features a socially empowered safety map app that enhances mobile GPS navigation using advanced proprietary technology.

[By Lisa Levin]

Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares dropped 32 percent to $6.87 after the company reported a common stock offering. The size of the offering was not disclosed. The company said that proceeds from the offering and warrants will be used to increase the company’s ownership stake in MoviePass.

Top 10 Heal Care Stocks To Own For 2018: Mastercard Incorporated(MA)

Advisors’ Opinion:

[By Dan Caplinger]

Visa Inc. (NYSE:V) and MasterCard (NYSE:MA) aren’t the only two players in the credit card and electronic payments space, but they are the biggest and best-known. Both Visa and MasterCard have extended their reach across the globe, and both have high expectations in their trajectories for future growth. Yet after a big push in the stock market that has sent both of these financial stocks to all-time highs, investors need to know which of the two leaders in the card industry is more deserving of their attention. Let’s take a closer look at Visa and MasterCard, comparing them using several different metrics to see which company’s shares are the better buy.

[By Matthew Cochrane]

Keeping these statistics in mind, one can see how marrying these two concepts would be equivalent to finding the Holy Grail of payments. This is how Mastercard Inc (NYSE:MA), clearly one of the giants in the payments space, plans to capture market share and win more card issuer deals by making payments as safe and frictionless as possible.

[By John Ballard]

Partnerships play a crucial role in extending PayPal’s reach to new customers and driving higher engagement. The deal with Visa(NYSE:V) opened the door for partnerships with Mastercard(NYSE:MA), Citigroup(NYSE:C), and Fidelity National Information Services (NYSE:FIS). As a result, more deals will come that will increase PayPal’s relevancy and ubiquity in the mobile payment landscape.

[By ]

Card networks Visa (NYSE: V) and Mastercard (NYSE: MA), which benefit from the same tailwinds, aren’t much better, both with minuscule yields of 0.7%.

[By ]

Mastercard Inc. (MA) announced this week that it plans to employ new blockchain specialists in an upcoming hiring round of 175 technology developers, Coindesk reported. The new tech hires will work from Mastercard’s Ireland office, where its research and development business, Mastercard Labs, is headquartered. The company said the aim of the new hires is to further the development of more efficient payment systems. Last September, Mastercard filed a patent for a blockchain system recording purchase orders, invoices and transaction data. Then in November, the company filed another application for blockchain-based solutions aimed at increasing the speed of transaction settlements.

Top 10 Heal Care Stocks To Own For 2018: Radient Technologies (RTI)

Advisors’ Opinion:

[By Jim Robertson]

Shares of small cap natural compound and Cannabinoid extract stock Radient Technologies (CVE: RTI) have been taking off lately as the Company makes further progress commercializing its technology. The Company extracts natural compounds from a range of biological materials using microwave assisted processing (MAP), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield and cost. This technology is based on the selective and localized heating of the moisture present in all natural materials using microwaves as the energy source. This gives the Company a technological advantage and expertise in selectively depositing microwave energy into different parts of a biomass’ complicated chemical system form the core of our extraction advantage.

[By Bryan Murphy]

It’s been a long time in the coming, but there’s no denying the tipping point has been reached — cannabinoids are the foundation for a whole new kind of medicine. And, the work-to-date turning cannabis into pharmaceuticals has been very encouraging.

Problem: While the premise of cannabinoids as drugs has been validated, the science of creating large quantities of pure cannabinoids remains more ineffective than effective. Radient Technologies Inc (CVE:RTI) is about the change that, leveraging a means of extracting a lot of cannabinoid material from a source, and ensuring the highest-level of purity and quality.

Radient Technologies manufactures natural ingredients for global customers across a range of industries, including food and beverage, nutrition, supplements, pharmaceuticals and cosmetics. Using a proprietary, patented technology, Radient’s products are superior in quality and purity while manufactured at a significantly lower cost than other methods thanks to superior yields and efficiency.

To fully appreciate the science Radient has developed, however, one must understand the alternative methods currently employed.

With current approaches to create ingredients from an appropriate source, the material with the target compound or molecule in it is soaked in a solvent, heated, and then over the course of several hours the desired ingredient diffuses into the solvent. After filtration, drying, and other processing, that ingredient is finally isolated and then collected.

It works, but it’s far from ideal. Aside from the fact that this technique doesn’t work very well at large scale, yields are relatively low. Worse, many undesirable components can still be found in the extract, lowering the quality and purity of the ingredient.

Some of the stories about how cannabis has changed lives for the better are nothing less than astounding. Take Illinois resident Darren Miller as an example. In 2015 Miller was diagnosed with lung cancer that was later deemed terminal. Miller underwent chemotherapy, without much hope, but also began using high-THC Indica cannabis oil. Miller is alive today, and arguably shouldn’t be.

Then there’s Floridian Branden Petro. Not only does Petro suffer epilepsy, he commonly experiences seizures stemming from the condition. Nothing has stopped the seizures as quickly or effectively as 200 milligram worth of THC cannabis oil, administered as a nasal spray. Within 20 seconds of using it, it’s as of the seizure never happened.

And there are millions of other such (and less dramatic) examples, all pointing in the same direction – cannabis has medical value on multiple fronts. Not facilitating its commercialization is a wasted opportunity.

It’s a notion that’s far from lost on the people that have built Canadian-based Radient Technologies Inc (CVE:RTI) from the round up, recently inking a deal with supplier of cannabinoid extracts, Aurora Cannabis.

It’s a real accolade. Aurora is one of the largest licensed producers of medical cannabis under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR), and recently began construction on an unprecedented 800,000 square foot production facility in Leduc County, Alberta. This facility, known as “Aurora Sky”, is anticipated to be capable of producing in excess of 100,000 kg of high-quality, low-cost marijuana per year.

In most regards though, Radient Technologies is the big winner of the deal, as the partnership is apt to put its high-tech facility in full demand, helping to advance the advent of cannabis in all its potential glory.

Many analysts have voiced fears that the U.S. stock markets march higher is overdone.

One chart watcher, on the other hand, is suggesting the opposite.

The breakout could be just getting started, wrote Jonathan Krinsky, chief market technician at MKM Partners, in a note dated Sunday.

This view comes after Krinsky looked not at the S&P 500
SPX, +0.39%
or the Dows
DJIA, +0.36%
30 blue chips, but rather at the Value Line Geometric Index
VALUG, +0.35%
, which consists of about 1,675 U.S. stocks.

Lincoln National Corp. (NYSE: LNC) also had the man at the top selling stock last week. Dennis Glass, the CEO of this insurance and retirement focused company, sold a block of 75,000 shares at between $71.00 and $71.28 apiece. The total for the sale was posted at $5 million. Shares closed Friday at $71.69, in a 52-week rangeof $34.16 to $73.71. The consensus price target is $73.17.

[By WWW.THESTREET.COM]

* The market bent yesterday but today it stabilized. (A good showing, all things being considered–but in no way decisive going forward). * Gold +$5/oz. * Crude oil +$0.50 and the rise is taking up some energy stocks. * The Russell returned to the spotlight. * Life insurance–particularly Lincoln National (LNC) (on an upgrade). Hartford Financial Services (HIG) gets a small lift. * Retail returned from the depths. The standouts–L Brands (LB) , Kohl’s (KSS) , Bed Bath (BBBY) , Nordstrom (JWN) and Gap (GPS) . * Ag equipment–after an analyst upgrade yesterday. * Brokerages. * Homebuilders catch a bid. * Day one of the Masters Golf Tournament.

Investors looking to set up a pair trade to capitalize on the divergent paths of U.S. and European banks should consider going long the iShares Dow Jones US Financial (ETF) (NYSE: IYF) and short the Ishares MSCI Europe Fincls Sctr Indx Fd (NASDAQ: EUFN).

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shares shot up 53 percent to $114.87 after the company impressed investors with encouraging data from a phase 3 clinical trial. Alnylam, a company dedicated towards treating a wide range of debilitating diseases through ribonucleic acid (RNA) interference (RNAi) therapeutics, said after Tuesday's market close that a phase 3 study called APOLLO met its primary efficacy endpoint and all secondary endpoints.

[By Cory Renauer]

Treating diseases that have a genetic component by altering the expression of the responsible genes is a promising new field of medicine, but it has been much less straightforward than biopharmaceutical companies had expected. Two contenders in this area, Alnylam Pharmaceuticals (NASDAQ:ALNY) and Ionis Pharmaceuticals (NASDAQ:IONS), saw a mix of setbacks and success in 2016.

[By Chris Dier-Scalise]

On Thursday, the Vetr crowd downgraded Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) from 4.5 stars (Strong Buy), which was issued two days ago, to 3.5 stars (Hold). Crowd sentiment for Alnylam at the time of the downgrade was edging positive, with 66 percent of Vetr user rating bullish.

[By Brian Orelli]

Alnylam Pharmaceuticals (NASDAQ:ALNY) jumped as much as 14.5% today after announcing earnings after the bell yesterday. As a development-stage biotech, it wasn’t the revenue or the earnings that caused the spike, but the progression of Allnylam’s pipeline.

[By Ben Levisohn]

Yesterday, after markets closed, it was announced that US Federal District Court Judge Sue Robinson ruled to issue a permanent injunction against Praluent, the PCSK9 mAb for hypercholesterolemia from partners Regeneron and Sanofi, due to infringement of patents from Amgen. The court has imposed a 30-day suspension (stay) on the injunction to allow for settlement or appeal of the District Court decision. Sanofi and Regeneron have announced their intent to appeal the ruling to the US Court of Appeals for the Federal Circuit (CAFC). The injunction decision is consistent with our counter-consensus published views communicated on 25 January 2016 (“Downgrade to Sell on evidence of likely infringement of Amgen’s PCSK9 patents”) and subsequently. Based on consultation with expert legal counsel, we now put >75% probability Amgen will prevail on appeal and/or Praluent is ultimately removed from the US market, and/or Amgen achieves a settlement substantially in its favor. We currently model $3.3 bn in non-risk-adjusted 2022E US revenues for Praluent, while consensus models $1.2 bn in 2022E US revenues. We reiterate our view from 25 January 2016 to preferentially own Amgen, The Medicines Company (MDCO) (Buy), and Alnylam (ALNY) (Buy) over Regeneron for exposure to PCSK9 inhibitor market dynamics as outcomes trials approach.

You see, Chinse web giant Alibaba Group Holding Ltd (NYSE: BABA) on Thursday said that that it beat first-quarter revenue estimates – but fell short on earnings.

I don’t care.

I know there are Wall Street types out there reading this that are probably crossing themselves three times and waiting for a lightning bolt from the sky – or from Goldman Sachs Group Inc. (NYSE: GS) – to strike me dead.

But this is truly how I feel.

And shrewd investors should feel the same way.

The fact is that it really doesn’t matter how Alibaba does this quarter… or next quarter… or even next year.

Because this is one of the few stocks out there we can point to and say – with true conviction and a high degree of certainty – this is a pretty doggone clear path to wealth.

stock marker: Aclaris Therapeutics, Inc.(ACRS)

Advisors’ Opinion:

[By Chris Lange]

Aclaris Therapeutics Inc. (NASDAQ: ACRS) saw its shares make a handy gain on Friday after the company announced the pricing of its secondary offering. The company intends to price its 4 million shares at $22.75 per share, with an overallotment option for an additional 600,000 shares. At this price the entire offering is valued up to $104.65 million.

[By Peter Graham]

Small cap hair loss stocks Aclaris Therapeutics (NASDAQ: ACRS), Cytori Therapeutics (NASDAQ: CYTX) and RepliCel Life Sciences (OTCQB: REPCF; CVE: RP) are trying to tap into a big market as currently, there are only two FDA-approved drugs available for the treatment of Androgenetic Alopecia (AGA) -also known as male or female pattern baldness (one of which cannot be used by women). Thus, a significant unmet need exists for a safe andefficacious product especially since its experienced by 70% of men and 40% of women as they age.

stock marker: Arc Wireless Solutions Inc.(ARCW)

Advisors’ Opinion:

[By Jim Robertson]

On Thursday, our Under the Radar Moversnewsletter suggested small cap manufacturing and 3D printing service provider ARC Group WorldWide (NASDAQ: ARCW) as a short trade:

stock marker: Outerwall Inc.(OUTR)

Advisors’ Opinion:

[By Monica Gerson]

Shares of Outerwall Inc (NASDAQ: OUTR) surged over 8 percent in Monday’s after-hours trading session following news for investors the company has begun the process of exploring strategic and financial alternatives. Outerwall’s Board also announced the raising of the company’s quarterly dividend from $0.30 to $0.60 per share. Outerwall shares jumped 8.11 percent to $37.18 in the after-hours trading session.

[By Jake L’Ecuyer]

Equities Trading DOWN Shares of Outerwall (NASDAQ: OUTR) were down 16.03 percent to $47.00 after the company lowered its forecast for the third quarter and full year. Werner Enterprises (NASDAQ: WERN) shares tumbled 4.71 percent to $23.26 after the company issued a weak third-quarter profit forecast. Bank of America downgraded the stock from Buy to Neutral. Pandora Media (NYSE: P) down, falling 1.71 percent to $23.58 as the company announced its plans to sell 14 million shares of common stock, including 4 million shares from current stockholders.

[By Peter Graham]

A long term performance chart shows shares of Netflix close to all time highsgoing into earnings while potential performance peer or competitor Amazon.com, Inc (NASDAQ: AMZN) has continueda more steadyrise and small cap Outerwall Inc (NASDAQ: OUTR), which owned the Redbox business,got swallowed up Apollo Global Management, LLC (NYSE: APO) late last year:

stock marker: Cowen Group, Inc.(COWN)

Advisors’ Opinion:

[By Lisa Levin]

Cowen Group Inc (NASDAQ: COWN) shares were also up, gaining 17 percent to $15.80 after the company posted upbeat Q1 earnings.

Post navigation

Vident Investment Advisory LLC boosted its holdings in McDonald's Co. (NYSE:MCD) by 6.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,817 shares of the fast-food giant’s stock after buying an additi

Tahoe Resources Inc (TSE:THO) (NASDAQ:TAHO) has received a consensus rating of “Hold” from the nine brokerages that are covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to

News stories about AVX (NYSE:AVX) have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative